Bausch + Lomb buys MID Labs from Hoya
What's the deal? HoyaDealroom has a profile for this one. Try Dealroom → has agreed to sell its entire stake in subsidiary Medical Instrument Development Laboratories (MID Labs) to Bausch + LombDealroom has a profile for this one. Try Dealroom →. The sale covers all 3,648,539 shares Hoya holds in the unit, with closing scheduled for November 2. Terms were not disclosed.
What's the endgame? The deal hands MID Labs, a maker of ophthalmic surgical instruments, to Bausch + Lomb, one of the largest eye-health companies, and removes the business from Hoya's portfolio.
The signal: The transaction reflects continued consolidation in the eye-care sector, as larger players absorb specialist manufacturers to broaden their surgical offerings.
Read more: ewintelligence.com
Image credit: Rotary Club of Nagpur
